Brain Influx of Endogenous Peptides Affecting Food Intake

Blood-Spinal Cord and Brain Barriers in Health and Disease

Volumn , Issue , 2004, Pages 57-62

  Kastin, Abba J ^a   Pan, Weihong ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84942886255     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012639011-7/50010-3     Document Type: Chapter

References (65)

1. Advokat C., Gulati A. Spinal transection reduced both spinal antinociception and CNS concentration of systemically administered morphine in rats. Brain Res. 1991, 555:251-258.
2. Asakawa A., Inui A., Ueno N., Fujimiya M., Fujino M., Kasuga M. Mouse pancreatic polypeptide modulates food intake, while not influencing anxiety in mice. Peptides 1999, 1445-1448.
3. Asakawa A., Inui A., Ueno N., Makino S., Fujino M.A., Kasuga M. Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice. Gastroenterology 1999, 116:1287-1292.
4. Banks W.A., Clever C.M., Farrell C.L. Partial saturation and regional variation in the transport of leptin across the blood-brain barrier in normal weight mice. Am. J. Physiol. 2000, 278:E1158-E1165.
5. Banks W.A., DiPalma C.R., Farrell C.L. Impaired transport of leptin across the blood-brain barrier in obesity. Peptides 1999, 20:1341-1345.
6. Banks W.A., Jaspan J.B., Huang W., Kastin A.J. Transport of insulin across the blood-brain barrier: Saturability at euglycemic doses of insulin. Peptides 1997, 18:1423-1429.
7. Banks W.A., Jaspan J.B., Kastin A.J. Effect of diabetes mellitus on the permeability of the blood-brain barrier to insulin. Peptides 1997, 18:1577-1584.
8. Banks W.A., Jaspan J.B., Kastin A.J. Selective, physiological transport of insulin across the blood-brain barrier: Novel demonstration by species-specific radioimmunoassay. Peptides 1997, 18:1257-1262.
9. Banks W.A., Kastin A.J. Peptides and the blood-brain barrier: Lipophilicity as a predictor of permeability. Brain Res. Bull. 1985, 15:287-292.
10. Banks W.A., Kastin A.J. Measurement of transport of cytokines across the blood-brain barrier. Neurobiology of Cytokines, Part A 1993, 67-77. Academic Press, San Diego. P.M. Conn, E.B. De Souza (Eds.).
11. Banks W.A., Kastin A.J. Opposite direction of transport across the blood-brain barrier for Tyr-MIF-1 and MIF-1: Comparison with morphine. Peptides 1994, 15:23-29.
12. Banks W.A., Kastin A.J. Permeability of the blood-brain barrier to melanocortins. Peptides 1995, 16:1157-1161.
13. Banks W.A., Kastin A.J. Regional variation in transport of pancreatic polypeptide across the blood-brain barrier. Pharmacol. Biochem. Behav. 1995, 51:139-147.
14. Banks W.A., Kastin A.J. Differential permeability of the blood-brain barrier to two pancreatic peptides: Insulin and amylin. Peptides 1998, 19:883-889.
15. Banks W.A., Kastin A.J., Akestrom V., Jaspan J.B. Radioactively iodinated cyclo(His-Pro) crosses the blood-brain barrier and reverses ethanol-induced narcosis. Am. J. Physiol. 1993, 267:E723-E729.
16. Banks W.A., Kastin A.J., Huang W., Jaspan J.B., Maness L.M. Leptin enters the brain by a saturable system independent of insulin. Peptides 1996, 17:305-311.
17. Banks W.A., Kastin A.J., Maness L.M., Huang W., Jaspan J.B. Permeability of the blood-brain barrier to amylin. Life Sci. 1995, 57:1993-2001.
18. Baura G.D., Foster D.M., Porte D., Kahn S.E., Bergman R.N., Cobelli C., Schwartz M.W. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo: A mechanism for regulated insulin delivery to the brain. J. Clin. Invest. 1993, 92:1824-1830.
19. Blasberg R.G., Fenstermacher J.D., Patlak C.S. Transport of α-aminoisobutyric acid across brain capillary and cellular membranes. J. Cereb. Blood Flow Metab. 1983, 3:8-22.
20. Caro J.F., Kolaczynski J.W., Nyce M.R., Ohannesian J.P., Opentanova I., Goldman W.H., Lynn R.B., Zhang P.-L., Sinha M.K., Considine R.V. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance. Lancet 1996, 348:159-161.
21. Chikhale E.G., Ng K.Y., Burton P.S., Borchardt R.T. Hydrogen bonding potential as a determinant of the in vitro and in situ blood-brain barrier permeability of peptides. Pharm. Res. 1994, 11:412-419.
22. Davson H., Segal M.B. Physiology of the CSF and Blood-Brain Barriers 1995, CRC Press, New York.
23. Dinulescu D.M., Fan W., Boston B.A., McCall K., Lamoreux M.L., Moore K.J., Montagno J., Cone R.D. Mahogany (mg) stimulates feeding and increases basal metabolic rate independent of its suppression of agouti. Proc. Natl. Acad. Sci. USA 1998, 95:12707-12712.
24. Forbes S., Bui S., Robinson B.R., Hochgeschwender U., Brennan M.B. Integrated control of appetite and fat metabolism by the leptin-proopiomelanocortin pathway. Proc. Natl. Acad. Sci. USA 2001, 98:4233-4237.
25. Kastin A.J., Akerstrom V. Entry of CART into brain is rapid but not inhibited by excess CART or leptin. Am. J. Physiol. 1999, 277:E901-E904.
26. Kastin A.J., Akerstrom V. Orexin A but not orexin B rapidly enters brain from blood by simple diffusion. J. Pharmacol. Exp. Ther. 1999, 289:219-223.
27. Kastin A.J., Akerstrom V. Nonsaturable entry of neuropeptide Y into brain. Am. J. Physiol. 1999, 276:E479-E482.
28. Kastin A.J., Akerstrom V. Fasting, but not adrenalectomy, reduces transport of leptin into the brain. Peptides 2000, 21:679-682.
29. Kastin A.J., Akerstrom V. Mahogany (1377-1428) enters brain by a saturable transport system. J. Pharmacol. Exp. Ther. 2000, 294:633-636.
30. Kastin A.J., Akerstrom V. Glucose and insulin increase the transport of leptin through the blood-brain barrier in normal mice but not in streptozotocin-diabetic mice. Neuroendocrinology 2001, 73:237-242.
31. Kastin A.J., Akerstrom V. Pretreatment with glucose increases entry of urocortin into mouse brain. Peptides 2001, 22:829-834.
32. Kastin A.J., Akerstrom V., Hackler L. Agouti-related protein (83-132) aggregates and crosses the blood-brain barrier slowly. Metabolism 2000, 49:1444-1448.
33. Kastin A.J., Akerstrom V., Hackler L. Food deprivation decreases blood galanin-like peptide (GALP) and its rapid entry into brain. Neuroendocrinology 2001, 74:423-432.
34. Kastin A.J., Akerstrom V., Hackler L., Pan W. Adrenomedullin and the blood-brain barrier. Horm. Metab. Res. 2001, 33:19-25.
35. 19-melanin-concentrating hormone and the blood-brain barrier. Role of protein binding. J. Neurochem. 2000, 74:385-391.
36. Kastin A.J., Akerstrom V., Pan W. Activation of urocortin transport into brain by leptin. Peptides 2000, 21:1811-1818.
37. Kastin A.J., Akerstrom V., Pan W. Validity of multiple-time regression analysis in measurement of tritiated and iodinated leptin crossing the blood-brain barrier Meaningful controls. Peptides 2001, 22:2127-2136.
38. Kastin A.J., Pan W. Dynamic regulation of leptin entry into brain by the blood-brain barrier. Regul. Pept. 2000, 92:37-43.
39. Kastin A.J., Pan W., Maness L.M., Koletsky R.J., Ernsberger P. Decreased transport of leptin across the blood-brain barrier in rats lacking the short form of the leptin receptor. Peptides 1999, 20:1449-1453.
40. Kastin A.J., Wade L.A., Coy D.H., Schally A.V., Olson R.D. Peptides and the blood-brain barrier. Brain and Pituitary Peptides 1980, 71-78.
41. Koistinen H.A., Karonen S.-L., Iivanainen M., Koivisto V.A. Circulating leptin has saturable transport into intrathecal space in humans. Eur. J. Clin. Invest. 1998, 28:894-897.
42. Kyrkouli S.E., Stanley B.G., Seirafi R.D., Leibowitz S.F. Stimulation of feeding by galanin: Anatomical localization and behavioral specificity of this peptide's effects in the brain. Peptides 1990, 11:995-1001.
43. Larm J.A., Gundlach A.L. Galanin-like peptide (GALP) mRNA expression is restricted to arcuate nucleus of hypothalamus in adult male rat brain. Neuroendocrinology 2000, 72:67-71.
44. Maness L.M., Banks W.A., Kastin A.J. Persistence of blood-to-brain transport of leptin in obese leptin-deficient and leptin receptor-deficient mice. Brain Res. 2000, 873:165-167.
45. Maness L.M., Kastin A.J., Farrell C.L., Banks W.A. Fate of leptin after intracerebroventricular injection into the mouse brain. Endocrinology 1998, 139:4556-4562.
46. Maresh G.A., Maness L.M., Zadina J.E., Kastin A.J. In vitro demonstration of a saturable transport system for leptin across the blood-brain barrier. Life Sci. 2001, 69:67-73.
47. Martins J.M., Banks W.A., Kastin A.J. Acute modulation of the active carrier-mediated brain-to-blood transport of corticotropin-releasing hormone. Am. J. Physiol. 1997, 272:E312-E319.
48. Martins J.M., Kastin A.J., Banks W.A. Unidirectional specific and modulated brain to blood transport of corticotropin-releasing hormone. Neuroendocrinology 1996, 63:338-348.
49. Nagle D.L., McGrail S.H., Vitale J., Woolf E.A., Dussault B.J., DiRocco L., Holmgren L., Montagno J., Bork P., Huszar D., Fairchild-Huntress V., Ge P., Keilty J., Ebeling C., Baldini L., Gilchrist J., Burn P., Carlson G.A., Moore K.J. The mahogany protein is a receptor involved in suppression of obesity. Nature 1999, 398:148-152.
50. Ohtaki T., Kumano S., Ishibashi Y., Ogi K., Matsui H., Harada M., Kitada C., Kurokawa T., Onda H., Fujino M. Isolation and cDNA cloning of a novel galanin-like peptide (GALP) from porcine hypothalamus. J. Biol. Chem. 1999, 274:37041-37045.
51. Pan W., Kastin A.J. Diurnal variation of leptin entry from blood to brain involving partial saturation of the transport system. Life Sci. 2001, 68:2705-2714.
52. Patlak C.S., Blasberg R.G., Fenstermacher J.D. Graphical evaluation of blood-to-brain transfer constants from multiple time uptake data. J. Cereb. Blood Flow Metab. 1983, 3:1-7.
53. Prasad C., Mori M., Wilber J.F., Pierson W., Pegues J., Jayaraman A. Distribution and metabolism of cyclo (His-Pro): A new member of the neuropeptide family. Peptides 1982, 3:591-598.
54. Preston E., Hynie I. Transfer constants for blood-brain barrier permeation of the neuroexcitatory shellfish toxin, domoic acid. Can. J. Neurol. Sci. 1991, 18:39-44.
55. Schwartz M.W., Peskind E., Raskind M., Boyko E.J., Porte D. Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans. Nature Med. 1996, 2:589-593.
56. 2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia. Neuroreport 1998, 9:1601-1606.
57. Spina m., Merlo-Pich E., Chan R.K.W., Basso A.M., Rivier J., Vale W., Koob G.F. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 1996, 273:1561-1564.
58. Takatsu Y., Matsumoto H., Ohtaki T., Kumano S., Kitada C., Onda H., Osamu N., Fujino M. Distribution of galanin-like peptide in the rat brain. Endocrinology 2001, 142:1626-1634.
59. Thomas S.A., Preston J.E., Wilson M.R., Farrell C.L., Segal M.B. Leptin transport at the blood-cerebrospinal fluid barrier using the perfused sheep choroid plexus model. Brain Res. 2001, 895:283-290.
60. Van Heek M., Compton D.S., France C.F., Tedesco R.P., Fawzi A.B., Graziano M.P., Sybertz E.J., Strader C.D., Davis H.R. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J. Clin. Invest. 1997, 99:385-390.
61. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., Chan R., Turnbull A.V., Lovejoy D., Rivier C., Rivier J., Sawchenko P.E., Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin 1 and to corticotropin-releasing factor. Nature 1995, 378:287-292.
62. Waters S.M., Krause J.E. Distribution of galanin-1,-2 and -3 receptor messenger RNAs in central and peripheral rat tissues. Neuroscience 2000, 95:265-271.
63. Wilson J.F., Anderson S., Snook G., LLewellyn K.D. Quantification of the permeability of the blood-CSF barrier to α-MSH in the rat. Peptides 1984, 5:681-685.
64. Wu-Peng X.S., Chua S.C., Okada N., Liu S.-M., Nicolson M., Leibel R.L. Phenotype of obese Koletsky (f) rat due to Tyr763 stop mutation in the extracellular domain of the leptin, receptor (lepr). Diabetes 1997, 46:513-518.
65. Zlokovic B.V., Jovanovic S., Miao W., Samara S., Verma S., Farrell C.L. Differential regulation of leptin transport by the choroid plexus and blood-brain barrier and high affinity transport systems for entry into hypothalamus and across the blood-cerebrospinal fluid barrier. Endocrinology 2000, 141:1434-1441.